STACIA DUNSON: Open Payments
NPI 1689929366 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 20 payments from 8 companies in 2025. Trend: 2023 $707 · 2024 $786 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $177 |
| Lilly USA, LLC | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $54 |
| ABBVIE INC. | 2 | $53 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Corcept Therapeutics | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: BREZTRI, JARDIANCE, FARXIGA, Rybelsus, MOUNJARO, ONZETRA XSAIL, VRAYLAR, LINZESS.
Industry payments across MS — which companies pay providers there.
